NHIV NHIV
Company Profile ↓Company Overview
NHIV (NHIV) is a publicly traded company listed on with a market capitalization of $251.94M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +1.09% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | +0.79% |
- RSI (14)62.19 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2025 | Mar 2026 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | - | - |
| Gross Profit | - | - |
| Operating Expenses | 47.00K | 38.00K |
| Operating Income | -47.00K | -38.00K |
| EBITDA | -47.00K | -38.00K |
| Interest Expense | - | - |
| Pretax Income | -47.00K | -38.00K |
| Tax Provision | - | - |
| Net Income | -47.00K | -38.00K |
| Diluted EPS | -0.00 | -0.00 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2025 |
|---|---|
| Total Assets | 91.00K |
| Current Assets | 8.00K |
| Cash & Equivalents | - |
| Inventory | - |
| Receivables | - |
| Total Liabilities | 113.00K |
| Current Liabilities | 113.00K |
| Long Term Debt | - |
| Total Debt | - |
| Total Equity | -22.00K |
| Shares Outstanding | 24.80M |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NHIV
NewHold Investment Corp IV (NHIV) Stock Price, News & Analysis - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5Edi1pSUVCdTJxTnRBWUlCLUlXUTFtdFYzS3Nxd0hFcWJqU29iNmc3Wi1aM1d6NmxjbGxUSndoaHJWb29VaTJhQjI3SXMyNnI3ZGpkekxvWVl0dw?oc=5" target="_blank">NewHold Investment Corp IV (NHIV) Stock Price…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9vMUFXbXB3Y1poeXM2NFV0VzN3WWdDSlVDNy1LdHozWGlub0xJN1ZMNnFROWF4b3pFbV9za2VoWTRLaHp3V2IzY2g2TDJJUERV?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
NHIV|NewHold Investment IV Ord Shs Class A|Price:10.160|Chg%:+0.010 - TradingKey
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE00NWVlLVF1ZWJPNmVPeElaOG01WjJaTnFvV1J5MVBSRERlbXZ2YzE3MldSSDRpSGY3SVNrcC1vSVhwenVLTXVxWENIZ2RJZjZKX0VsNDV0SVBUQQ?oc=5" target="_blank">NHIV|NewHold Investment IV Ord Shs Class A|Pr…
Price to earnings forward of NewHold Investment Corp IV – NASDAQ:NHIV - TradingView
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQanlzSVktWXEwTl9rczdmOGR1QTV1M3lDWHlMVDFqLW1DOW94c1AyNC1ZSGxUMlJySDRrN2hwV1VKU2txWGZzc0cwaGdfb3NpS014YkRJY2dGUjlEZTJhNTIyUllWZXlkNzBwTF9NQU9OTHdTM053cU1lUTBua0l2cHFPS3NWLVU5RTA1Yn…
NHIV | NewHold Investment Corp IV Institutional Ownership - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTFBseVUtUnVLcGVUVWVRdzZtUVpJb3JJZjk2aTFqd2ZVZzh0aGRkWE5yR09xeV9BbE9lZHVBbGhBeXFxWldvZEpKaDM0b1prMmVGWUxqR2tEMEYtRmhSX0xGNV9B?oc=5" target="_blank">NHIV | NewHold Investment Corp IV I…
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong. - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPemtSazhHR2l3cm10cXdob29saU5wZFBkT1F4VTBnRktJNElkUE05a2FvNlNweC1KQjdJQVFwMVB2MDVvS3JYRmd1TjR4dWlCblBUZkZGYWdiQ0lWaTVYUElrcjZVTXJxZVBPclIzYjlhMkFuc2w1ekRQTDlJX3hEUEg4RjZwSmdiNl9QVD…
NHIV — Frequently Asked Questions
What is the current share price of NHIV?
As of 2026-08-05 17:25 PDT, NHIV trades at $10.16 on NASDAQ/NYSE. Its 52-week range is $9.95 to $10.16.
What is the market capitalisation of NHIV?
NHIV has a market capitalisation of $251.94M on NASDAQ/NYSE.
Is NHIV a good stock to buy?
This page provides a data-driven analysis of NHIV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.